Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand

AstraZeneca1,020 enrolled

Overview

The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.

Study Type

OBSERVATIONAL

Enrollment

1,020

Conditions

Asthma

Eligibility

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Established persistent asthma * Currently treated with Symbicort SMART for 3 months or longer Exclusion Criteria: * currently participating or have participated in a study with an investigational compound within the last 30 days * current diagnosis of chronic obstructive pulmonary disease (COPD) * smoked more than 10 pack-year

Locations (14)

Research Site

Buriram, Thailand

Research Site

Chanthaburi, Thailand

Research Site

Chiang Mai, Thailand

Research Site

Outcomes

Primary Outcomes

Number of budesonide/formoterol use per patient

Time frame: On the survey date

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.